Nuzenio

Is Halozyme Therapeutics

Is Halozyme Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Halozyme Therapeutics (HALO) Is Up 24.9% After Record Q2, Higher 2026 Guidance And New ENHANZE Deals - Has The Bull Case Changed? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 13:13:58 GMT Halozyme Therapeutics (HALO) Is Up 24.9% After Raising 2026 Revenue Outlook and Boosting Buybacks - Yahoo FinanceYahoo Finance · Sun, 09 Aug 2026 00:19:00 GMT Halozyme Therapeutics (HALO) Stock Looks Expensive At Today’s Price - SahmSahm · Sat, 08 Aug 2026 19:11:31 GMT Is Halozyme Therapeutics (HALO) Fairly Valued As Earnings Beat And Guidance Rise? - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 16:12:05 GMT Halozyme (HALO) Stock Rallies As Royalties Surge And Guidance Climbs - simplywall.stsimplywall.st · Sat, 08 Aug 2026 14:36:47 GMT Halozyme Therapeutics (NASDAQ:HALO) Upgraded to Strong-Buy at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 07:55:11 GMT Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know - StockStoryStockStory · Sat, 08 Aug 2026 06:48:42 GMT Halozyme Therapeutics Inc (HALO) (Q2 2026) Earnings Call Highlights: Record Revenue and Royalty ... - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 03:06:00 GMT

Timeline

Sun, 09 Aug 2026 13:13:58 GMTHalozyme Therapeutics (HALO) Is Up 24.9% After Record Q2, Higher 2026 Guidance And New ENHANZE Deals - Has The Bull Case Changed? - simplywall.st

Sun, 09 Aug 2026 00:19:00 GMTHalozyme Therapeutics (HALO) Is Up 24.9% After Raising 2026 Revenue Outlook and Boosting Buybacks - Yahoo Finance

Sat, 08 Aug 2026 19:11:31 GMTHalozyme Therapeutics (HALO) Stock Looks Expensive At Today’s Price - Sahm

Sat, 08 Aug 2026 16:12:05 GMTIs Halozyme Therapeutics (HALO) Fairly Valued As Earnings Beat And Guidance Rise? - Yahoo Finance

Sat, 08 Aug 2026 14:36:47 GMTHalozyme (HALO) Stock Rallies As Royalties Surge And Guidance Climbs - simplywall.st

Sat, 08 Aug 2026 07:55:11 GMTHalozyme Therapeutics (NASDAQ:HALO) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

HALO29 live mentions Halozyme Therapeutics17 live mentions NASDAQ10 live mentions Inc8 live mentions Yahoo Finance Halozyme5 live mentions Therapeutics5 live mentions Is Up4 live mentions Higher4 live mentions Yahoo Finance Yahoo4 live mentions Finance4 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Is Halozyme Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.